ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 277 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q3 2022. The put-call ratio across all filers is 0.78 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2023 | $660,164 | +22.0% | 21,574 | +7.1% | 0.13% | +9.5% |
| Q3 2023 | $541,027 | -12.1% | 20,135 | +16.7% | 0.12% | -5.7% |
| Q2 2023 | $615,313 | +54.7% | 17,255 | +10.2% | 0.12% | +7.0% |
| Q1 2023 | $397,815 | -42.7% | 15,662 | -8.5% | 0.12% | -82.9% |
| Q4 2022 | $694,468 | +20.2% | 17,122 | -2.1% | 0.67% | +26.9% |
| Q3 2022 | $578,000 | -15.4% | 17,489 | -9.8% | 0.53% | +2.1% |
| Q2 2022 | $683,000 | -27.9% | 19,399 | -5.8% | 0.52% | +16.6% |
| Q1 2022 | $947,000 | -43.7% | 20,602 | -18.8% | 0.45% | -27.1% |
| Q4 2021 | $1,681,000 | – | 25,358 | – | 0.61% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 908,474 | $24,410,696 | 22.12% |
| Western Financial Corp/CA | 820,239 | $22,039,822 | 16.16% |
| JOHNSON & JOHNSON | 247,598 | $6,652,958 | 2.45% |
| WEALTH EFFECTS LLC | 164,750 | $4,426,835 | 2.19% |
| M28 Capital Management LP | 67,400 | $1,811,038 | 2.08% |
| Privium Fund Management B.V. | 259,036 | $6,960,298 | 2.07% |
| Evolutionary Tree Capital Management, LLC | 51,266 | $1,377,517 | 1.78% |
| Avidity Partners Management LP | 1,063,897 | $28,586,912 | 1.15% |
| SECTORAL ASSET MANAGEMENT INC | 157,552 | $4,233,422 | 0.82% |
| Vivo Capital, LLC | 137,411 | $3,692,234 | 0.40% |